Mosaic Family Wealth Partners LLC Makes New Investment in Colgate-Palmolive (NYSE:CL)

Mosaic Family Wealth Partners LLC bought a new position in Colgate-Palmolive (NYSE:CLFree Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,287 shares of the company’s stock, valued at approximately $206,000.

Other hedge funds also recently bought and sold shares of the company. Venturi Wealth Management LLC grew its position in Colgate-Palmolive by 3.6% in the fourth quarter. Venturi Wealth Management LLC now owns 4,298 shares of the company’s stock valued at $343,000 after purchasing an additional 150 shares in the last quarter. Ballentine Partners LLC grew its position in Colgate-Palmolive by 37.2% in the fourth quarter. Ballentine Partners LLC now owns 8,902 shares of the company’s stock valued at $710,000 after purchasing an additional 2,413 shares in the last quarter. Alera Investment Advisors LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $443,000. Autumn Glory Partners LLC grew its position in shares of Colgate-Palmolive by 2.7% in the 4th quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock valued at $424,000 after acquiring an additional 140 shares during the period. Finally, International Assets Investment Management LLC grew its position in shares of Colgate-Palmolive by 8,664.4% in the 4th quarter. International Assets Investment Management LLC now owns 287,473 shares of the company’s stock valued at $22,914,000 after acquiring an additional 284,193 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently commented on CL. Bank of America lifted their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Finally, Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 10th. Seven analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $101.11.

View Our Latest Research Report on CL

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded up $1.88 during midday trading on Friday, hitting $102.81. 5,088,982 shares of the company traded hands, compared to its average volume of 4,089,503. The stock has a market cap of $84.01 billion, a price-to-earnings ratio of 32.53, a PEG ratio of 3.54 and a beta of 0.39. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06. The firm’s fifty day moving average price is $96.49 and its 200-day moving average price is $90.84. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $103.35.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same period in the previous year, the firm posted $0.77 EPS. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date is Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.